{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:12:22Z","timestamp":1771866742967,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Defense, Japan"},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-013, H26-037, H23-012"],"award-info":[{"award-number":["H29-013, H26-037, H23-012"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan","doi-asserted-by":"crossref","award":["17913039, 26293250, 15K09640"],"award-info":[{"award-number":["17913039, 26293250, 15K09640"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Practical Research for Rare\/Intractable Diseases from Japan Agency for Medical Research and Development"},{"name":"Japan Foundation for Pediatric Research"},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012045","name":"Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012045","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10875-017-0466-7","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T20:07:05Z","timestamp":1513627625000},"page":"144-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2486-5343","authenticated-orcid":false,"given":"Yuki","family":"Tsujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Kamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Nonoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"issue":"4 Suppl","key":"466_CR1","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"JS Orange","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525\u201353. \nhttps:\/\/doi.org\/10.1016\/j.jaci.2006.01.015\n\n.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"466_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","volume":"135","author":"HW Eijkhout","year":"2001","unstructured":"Eijkhout HW, van Der Meer JW, Kallenberg CG, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001;135(3):165\u201374. \nhttps:\/\/doi.org\/10.7326\/0003-4819-135-3-200108070-00008\n\n.","journal-title":"Ann Intern Med"},{"issue":"2","key":"466_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0090-1229(77)90116-7","volume":"8","author":"JV Wells","year":"1977","unstructured":"Wells JV, Buckley RH, Schanfield MS, Fundenberg HH. Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. Clin Immunol Immunopathol. 1977;8(2):265\u201371. \nhttps:\/\/doi.org\/10.1016\/0090-1229(77)90116-7\n\n.","journal-title":"Clin Immunol Immunopathol"},{"issue":"7563","key":"466_CR4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(68)90527-8","volume":"2","author":"GN Vyas","year":"1968","unstructured":"Vyas GN, Perkins HA, Fudenberg HH. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet. 1968;2(7563):312\u20135.","journal-title":"Lancet"},{"issue":"1","key":"466_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0887-7963(05)80026-4","volume":"9","author":"SG Sandler","year":"1995","unstructured":"Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev. 1995;9(1):1\u20138. \nhttps:\/\/doi.org\/10.1016\/S0887-7963(05)80026-4\n\n.","journal-title":"Transfus Med Rev"},{"issue":"9","key":"466_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJM198602273140907","volume":"314","author":"AW Burks","year":"1986","unstructured":"Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med. 1986;314(9):560\u20134. \nhttps:\/\/doi.org\/10.1056\/NEJM198602273140907\n\n.","journal-title":"N Engl J Med"},{"key":"466_CR7","first-page":"467","volume":"16","author":"K Kitamura","year":"2002","unstructured":"Kitamura K, Mikami Y. Analysis of the physicochemical and biochemical property of various intravenous immunoglonbulin preparations. Biotherapy. 2002;16:467\u201376. (Article in Japanese)","journal-title":"Biotherapy"},{"key":"466_CR8","unstructured":"Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases. A molecular and genetic approach. Third edition, NY, USA, 2014. p. 299\u2013365."},{"issue":"5","key":"466_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565\u201375. \nhttps:\/\/doi.org\/10.1016\/S0092-8674(00)00079-9\n\n.","journal-title":"Cell"},{"issue":"4","key":"466_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1203\/00006450-198519040-00017","volume":"19","author":"U Fabry","year":"1985","unstructured":"Fabry U, K\u00f6rholz D, J\u00fcrgens H, G\u00f6bel U, Wahn V. Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children\u2014evidence of a complement-mediated mechanism. Pediatr Res. 1985;19(4):400\u20138. \nhttps:\/\/doi.org\/10.1203\/00006450-198519040-00017\n\n.","journal-title":"Pediatr Res"},{"issue":"1","key":"466_CR11","first-page":"41","volume":"50","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Nonoyama S, Morio T, Muramatsu M, Honjo T, Mizutani S. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci. 2003;50(1):41\u20136.","journal-title":"J Med Dent Sci"},{"issue":"3","key":"466_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/clim.2000.4956","volume":"97","author":"Y Minegishi","year":"2000","unstructured":"Minegishi Y, Lavoie A, Cunningham-Rundles C, B\u00e9dard PM, H\u00e9bert J, C\u00f4t\u00e9 L, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203\u201310. \nhttps:\/\/doi.org\/10.1006\/clim.2000.4956\n\n.","journal-title":"Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-017-0466-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T16:27:52Z","timestamp":1514219272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-017-0466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s10875-017-0466-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]}}}